Health And Medicine

A novel hormone deficiency may exist in humans, Vanderbilt investigators have discovered. In an analysis of two decades worth of electronic health records, the researchers found that some patients have unexpectedly low levels of natriuretic peptide hormone in clinical situations that should cause high levels of the hormone. Read More

A new genome-wide CRISPR screening technique conducted by researchers at Vanderbilt University is offering new insights about how tumors in 80 to 90 percent of all cancers grow. Read More

Strong, collaborative relationships with principal investigators are a key factor of longevity in clinical research coordinator positions — an essential, but increasingly transient job in executing treatment-advancing clinical trials, Vanderbilt University Medical Center researchers found. Read More

Men’s health across Tennessee is trending toward improvement, according to the 2020 Tennessee Men’s Health Report Card, but racial and geographic disparities persist. The report card is compiled by Vanderbilt’s Center for Research on Men’s Health in cooperation with Vanderbilt University Medical Center, the Tennessee Department of Health, Meharry Medical College and the Tennessee Men’s Health Network. Read More

The emergence of pathogenic skin fungi that cause the disease chytridiomycosis is contributing to the global loss of amphibian populations.  Read More

A monoclonal antibody “cocktail” developed at Vanderbilt University Medical Center to neutralize the COVID-19 virus is effective against all known strains, or variants, of the virus, according to a report published today in the journal Nature Medicine.... Read More

David DeMets, PhD, known for his work on statistical methods to monitor interim clinical trial data for early evidence of benefit or harm, will deliver the next web-based Discovery Lecture. Read More

Evotec, a drug company headquartered in Hamburg, Germany, has begun a phase 1 clinical trial of a monoclonal antibody against the chikungunya virus that was identified at Vanderbilt University Medical Center. Read More

VUSN Professor Dr. April Kapu, DNP, APRN, ACNP-BC, FAANP, FAAN, was recently interviewed by the Clinical Advisor per the controversy over USDA-HHS Dietary Guidelines. Dr. Kapu commented: “Obesity and detrimental effects of alcohol have tremendous negative consequences on health. I would encourage the USDA-HHS to continue study into the effects of sugar and alcohol consumption and evidence-based... Read More

A new partnership between Vanderbilt University’s Warren Center for Neuroscience Drug Discovery and clinical stage biopharmaceutical company Soleno Therapeutics will further research into new clinical treatments for multiple obesity syndromes. Read More

In Tampa, Florida, in the early 1980s, young men were coming home to their parents to die. As a registered nurse, Julie Barroso cared for many of these AIDS patients in their final days. Read More

Vanderbilt biochemist Yi Ren is part of a team that has identified a new behavior of a SARS-CoV-2 protein and discovered that interfering with its function can block virus replication in host cells. This opens up the potential for new therapeutic targets for COVID-19. Read More

Assistant Professor of Chemistry Steven D. Townsend, PhD’10, has been awarded a 2021 Sloan Research Fellowship, one of the highest honors for young scientists who have the potential to revolutionize their fields of study. Read More

Vanderbilt first-year students recently met with Buddy Creech, director of the Vanderbilt Vaccine Research Program and associate professor of pediatrics, for a special virtual chat to answer some of their COVID-19 vaccine questions. Read More

Bruce Carter, professor of biochemistry and an associate director of the Vanderbilt Brain Institute, has been appointed to the scientific advisory board of the CMT Research Foundation, which shapes research directions and therapeutic development of Charcot-Marie-Tooth disease. Read More

Biomedical researchers across Vanderbilt University will convene to discuss the history and impact of Black biomedical scientists on Monday, Feb. 15, at noon CT. Read More

A new method speeds the analysis of factors that control gene expression from days to minutes, allowing researchers to uncover new targets for cancer treatment. Read More

Researchers will combine expertise in developmental cell biology and tissue engineering/microfluidics to develop highly complex organoids, with the goal of understanding currently incurable neurological disorders.  Read More

Vanderbilt University has joined the Leap Health Breakthrough Network, a global group of leading academic and research institutions committed to solving the world’s most serious health challenges. Read More

For the second time, cancer researchers at Vanderbilt have discovered a protein that—when genetically manipulated to impede it from interacting with a gene responsible for cancer genesis—effectively melts tumors in days. Read More